Completed OBSERVATIONAL NCT04893057

COVID-19 Seroprevalence in Pregnant Women and Blood Donors (CoVERED)

SARS-CoV-2 sERoprévalences Dans la Population Des Femmes Enceintes et Donneurs de Sang

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions COVID-19 Respiratory Infection

Updated 7 times since 2021 Last updated: Oct 3, 2024 Started: Sep 15, 2022 Primary completion: Jan 4, 2023 Completion: Jan 4, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates COVID-19 Respiratory Infection and is currently completed. Centre Hospitalier Universitaire de Besancon leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Nov 2024 — Present [monthly]

Completed
Oct 2024 — Nov 2024 [monthly]

Completed

Status: Unknown → Completed
Sep 2024 — Oct 2024 [monthly]

Unknown
Aug 2024 — Sep 2024 [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting

▶ Show 2 earlier versions

Sep 2022 — Jul 2024 [monthly]

Not Yet Recruiting
Jun 2021 — Sep 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Besançon, France